O	0	9	Induction	Induction	NN	B-NP
O	10	12	of	of	IN	B-PP
O	13	16	Ets	Ets	NN	B-NP
O	16	17	-	-	HYPH	B-NP
O	17	18	1	1	CD	I-NP
O	19	21	in	in	IN	B-PP
B-Cell	22	33	endothelial	endothelial	JJ	B-NP
I-Cell	34	39	cells	cell	NNS	I-NP
O	40	46	during	during	IN	B-PP
O	47	67	reendothelialization	reendothelialization	NN	B-NP
O	68	73	after	after	IN	B-PP
O	74	82	denuding	denude	VBG	B-VP
O	83	89	injury	injury	NN	B-NP
O	89	90	.	.	.	O

O	91	94	Ets	Ets	NN	B-NP
O	94	95	-	-	HYPH	B-NP
O	95	96	1	1	CD	I-NP
O	96	97	,	,	,	O
O	98	99	a	a	DT	B-NP
O	100	113	transcription	transcription	NN	I-NP
O	114	120	factor	factor	NN	I-NP
O	120	121	,	,	,	O
O	122	124	is	be	VBZ	B-VP
O	125	132	induced	induce	VBN	I-VP
O	133	135	in	in	IN	B-PP
B-Cell	136	147	endothelial	endothelial	JJ	B-NP
I-Cell	148	153	cells	cell	NNS	I-NP
O	154	155	(	(	(	O
B-Cell	155	158	ECs	EC	NNS	B-NP
O	158	159	)	)	)	O
O	160	166	during	during	IN	B-PP
O	167	179	angiogenesis	angiogenesis	NN	B-NP
O	179	180	.	.	.	O

O	181	185	Here	Here	RB	B-ADVP
O	185	186	,	,	,	O
O	187	189	we	we	PRP	B-NP
O	190	202	investigated	investigate	VBD	B-VP
O	203	206	the	the	DT	B-NP
O	207	217	expression	expression	NN	I-NP
O	218	220	of	of	IN	B-PP
O	221	224	Ets	Ets	NN	B-NP
O	224	225	-	-	HYPH	B-NP
O	225	226	1	1	CD	I-NP
O	227	233	during	during	IN	B-PP
O	234	254	reendothelialization	reendothelialization	NN	B-NP
O	254	255	.	.	.	O

O	256	260	When	When	WRB	B-ADVP
O	261	262	a	a	DT	B-NP
O	263	272	confluent	confluent	JJ	I-NP
B-Cell	273	282	monolayer	monolayer	NN	I-NP
O	283	285	of	of	IN	B-PP
B-Cell	286	291	human	human	JJ	B-NP
I-Cell	292	301	umbilical	umbilical	JJ	I-NP
I-Cell	302	306	vein	vein	NN	I-NP
I-Cell	307	318	endothelial	endothelial	JJ	I-NP
I-Cell	319	323	cell	cell	NN	I-NP
I-Cell	324	328	line	line	NN	I-NP
O	328	329	,	,	,	O
B-Cell	330	336	ECV304	ECV304	NN	B-NP
O	336	337	,	,	,	O
O	338	341	was	be	VBD	B-VP
O	342	349	denuded	denude	VBN	I-VP
O	349	350	,	,	,	O
B-Cell	351	357	ECV304	ECV304	NN	B-NP
O	358	360	at	at	IN	B-PP
O	361	364	the	the	DT	B-NP
B-Pathological_formation	365	370	wound	wound	NN	I-NP
I-Pathological_formation	371	375	edge	edge	NN	I-NP
O	376	385	expressed	express	VBD	B-VP
O	386	389	Ets	Ets	NN	B-NP
O	389	390	-	-	HYPH	B-NP
O	390	391	1	1	CD	I-NP
O	391	392	.	.	.	O

O	393	395	An	An	DT	B-NP
O	396	415	immunohistochemical	immunohistochemical	JJ	I-NP
O	416	424	analysis	analysis	NN	I-NP
O	425	433	revealed	reveal	VBD	B-VP
O	434	438	that	that	IN	B-SBAR
O	439	442	Ets	Ets	NN	B-NP
O	442	443	-	-	HYPH	B-NP
O	443	444	1	1	CD	I-NP
O	445	456	accumulated	accumulate	VBN	B-VP
O	457	459	in	in	IN	B-PP
B-Cell	460	469	migrating	migrate	VBG	B-VP
I-Cell	470	475	cells	cell	NNS	B-NP
O	476	478	at	at	IN	B-PP
O	479	482	the	the	DT	B-NP
B-Pathological_formation	483	488	wound	wound	JJ	I-NP
I-Pathological_formation	489	493	edge	edge	NN	I-NP
O	494	497	and	and	CC	O
O	498	506	returned	return	VBD	B-VP
O	507	509	to	to	TO	B-PP
O	510	515	basal	basal	JJ	B-NP
O	516	521	level	level	NN	I-NP
O	522	526	when	when	WRB	B-ADVP
O	527	547	reendothelialization	reendothelialization	NN	B-NP
O	548	551	was	be	VBD	B-VP
O	552	564	accomplished	accomplish	VBN	I-VP
O	564	565	.	.	.	O

O	566	570	This	This	DT	B-NP
O	571	580	induction	induction	NN	I-NP
O	581	583	of	of	IN	B-PP
O	584	587	Ets	Ets	NN	B-NP
O	587	588	-	-	HYPH	B-NP
O	588	589	1	1	CD	I-NP
O	590	595	could	could	MD	B-VP
O	596	598	be	be	VB	I-VP
O	599	609	reproduced	reproduce	VBN	I-VP
O	610	612	in	in	IN	B-PP
O	613	615	in	in	FW	B-NP
O	616	620	vivo	vivo	FW	I-NP
O	621	631	denudation	denudation	NN	I-NP
O	632	634	of	of	IN	B-PP
O	635	638	rat	rat	NN	B-NP
B-Tissue	639	645	aortic	aortic	JJ	I-NP
I-Tissue	646	657	endothelium	endothelium	NN	I-NP
O	658	660	by	by	IN	B-PP
O	661	662	a	a	DT	B-NP
O	663	670	balloon	balloon	NN	I-NP
O	671	679	catheter	catheter	NN	I-NP
O	679	680	.	.	.	O

O	681	684	The	The	DT	B-NP
O	685	694	induction	induction	NN	I-NP
O	695	697	of	of	IN	B-PP
O	698	701	Ets	Ets	NN	B-NP
O	701	702	-	-	HYPH	B-NP
O	702	703	1	1	CD	I-NP
O	704	706	in	in	IN	B-PP
B-Cell	707	710	ECs	EC	NNS	B-NP
O	711	716	after	after	IN	B-SBAR
O	717	727	denudation	denudation	NN	B-NP
O	728	731	was	be	VBD	B-VP
O	732	741	regulated	regulate	VBN	I-VP
O	742	759	transcriptionally	transcriptionally	RB	B-ADVP
O	759	760	,	,	,	O
O	761	764	and	and	CC	O
O	765	772	humeral	humeral	JJ	B-NP
O	773	780	factors	factor	NNS	I-NP
O	781	789	released	release	VBN	B-VP
O	790	794	from	from	IN	B-PP
O	795	802	injured	injure	VBN	B-NP
B-Cell	803	806	ECs	EC	NNS	I-NP
O	807	812	might	might	MD	B-VP
O	813	816	not	not	RB	I-VP
O	817	819	be	be	VB	I-VP
O	820	831	responsible	responsible	JJ	B-ADJP
O	831	832	.	.	.	O

O	833	840	Mitogen	Mitogen	NN	B-NP
O	840	841	-	-	HYPH	B-PP
O	841	850	activated	activate	VBN	B-NP
O	851	858	protein	protein	NN	I-NP
O	859	865	kinase	kinase	NN	I-NP
O	866	867	(	(	(	O
O	867	871	MAPK	MAPK	NN	B-NP
O	871	872	)	)	)	O
O	873	883	activities	activity	NNS	B-NP
O	884	888	were	be	VBD	B-VP
O	889	901	investigated	investigate	VBN	I-VP
O	902	904	to	to	TO	B-VP
O	905	912	explore	explore	VB	I-VP
O	913	916	the	the	DT	B-NP
O	917	926	mechanism	mechanism	NN	I-NP
O	927	929	of	of	IN	B-PP
O	930	934	this	this	DT	B-NP
O	935	944	induction	induction	NN	I-NP
O	944	945	.	.	.	O

O	946	954	Although	Although	IN	B-SBAR
O	955	968	extracellular	extracellular	JJ	B-NP
O	969	975	signal	signal	NN	I-NP
O	975	976	-	-	HYPH	B-NP
O	976	985	regulated	regulate	VBN	I-NP
O	986	993	protein	protein	NN	I-NP
O	994	1000	kinase	kinase	NN	I-NP
O	1001	1002	1	1	CD	I-NP
O	1002	1003	/	/	SYM	I-NP
O	1003	1004	2	2	CD	I-NP
O	1005	1006	(	(	(	O
O	1006	1010	ERK1	ERK1	NN	B-NP
O	1010	1011	/	/	SYM	O
O	1011	1012	2	2	CD	B-NP
O	1012	1013	)	)	)	O
O	1013	1014	,	,	,	O
O	1015	1016	c	c	NN	B-NP
O	1016	1017	-	-	HYPH	O
O	1017	1020	Jun	Jun	NN	B-NP
O	1021	1022	N	N	NN	I-NP
O	1022	1023	-	-	HYPH	B-NP
O	1023	1031	terminal	terminal	JJ	I-NP
O	1032	1038	kinase	kinase	NN	I-NP
O	1039	1040	1	1	CD	I-NP
O	1041	1042	(	(	(	O
O	1042	1046	JNK1	JNK1	NN	B-NP
O	1046	1047	)	)	)	O
O	1047	1048	,	,	,	O
O	1049	1052	and	and	CC	O
O	1053	1056	p38	p38	NN	B-NP
O	1057	1061	were	be	VBD	B-VP
O	1062	1071	activated	activate	VBN	I-VP
O	1072	1077	after	after	IN	B-PP
O	1078	1088	denudation	denudation	NN	B-NP
O	1088	1089	,	,	,	O
O	1090	1093	the	the	DT	B-NP
O	1094	1104	activation	activation	NN	I-NP
O	1105	1107	of	of	IN	B-PP
O	1108	1112	ERK1	ERK1	NN	B-NP
O	1113	1116	and	and	CC	I-NP
O	1117	1120	p38	p38	NN	I-NP
O	1121	1124	was	be	VBD	B-VP
O	1125	1129	more	more	RBR	B-ADJP
O	1130	1135	rapid	rapid	JJ	I-ADJP
O	1136	1139	and	and	CC	I-ADJP
O	1140	1149	prominent	prominent	JJ	I-ADJP
O	1149	1150	.	.	.	O

O	1151	1158	PD98059	PD98059	NN	B-NP
O	1158	1159	,	,	,	O
O	1160	1161	a	a	DT	B-NP
O	1162	1170	specific	specific	JJ	I-NP
O	1171	1175	MAPK	MAPK	NN	I-NP
O	1175	1176	/	/	SYM	B-VP
O	1176	1179	ERK	ERK	NN	B-NP
O	1180	1186	kinase	kinase	NN	I-NP
O	1187	1188	(	(	(	O
O	1188	1191	MEK	MEK	NN	B-NP
O	1191	1192	)	)	)	O
O	1193	1194	1	1	CD	B-NP
O	1195	1204	inhibitor	inhibitor	NN	I-NP
O	1204	1205	,	,	,	O
O	1206	1209	did	do	VBD	B-VP
O	1210	1213	not	not	RB	I-VP
O	1214	1220	affect	affect	VB	I-VP
O	1221	1224	the	the	DT	B-NP
O	1225	1234	induction	induction	NN	I-NP
O	1235	1237	of	of	IN	B-PP
O	1238	1241	ets	ets	NN	B-NP
O	1241	1242	-	-	HYPH	B-NP
O	1242	1243	1	1	CD	I-NP
O	1244	1248	mRNA	mRNA	NN	I-NP
O	1248	1249	,	,	,	O
O	1250	1257	whereas	whereas	IN	O
O	1258	1266	SB203580	SB203580	NN	B-NP
O	1266	1267	,	,	,	O
O	1268	1269	a	a	DT	B-NP
O	1270	1278	specific	specific	JJ	I-NP
O	1279	1282	p38	p38	NN	I-NP
O	1283	1292	inhibitor	inhibitor	NN	I-NP
O	1292	1293	,	,	,	O
O	1294	1300	almost	almost	RB	B-ADVP
O	1301	1311	completely	completely	RB	I-ADVP
O	1312	1321	abrogated	abrogate	VBD	B-VP
O	1322	1325	its	its	PRP$	B-NP
O	1326	1335	induction	induction	NN	I-NP
O	1335	1336	.	.	.	O

O	1337	1342	These	These	DT	B-NP
O	1343	1350	results	result	NNS	I-NP
O	1351	1359	indicate	indicate	VBP	B-VP
O	1360	1364	that	that	IN	B-SBAR
O	1365	1368	Ets	Ets	NN	B-NP
O	1368	1369	-	-	HYPH	B-NP
O	1369	1370	1	1	CD	I-NP
O	1371	1373	is	be	VBZ	B-VP
O	1374	1381	induced	induce	VBN	I-VP
O	1382	1384	in	in	IN	B-PP
B-Cell	1385	1388	ECs	EC	NNS	B-NP
O	1389	1394	after	after	IN	B-PP
O	1395	1405	denudation	denudation	NN	B-NP
O	1406	1413	through	through	IN	B-PP
O	1414	1424	activation	activation	NN	B-NP
O	1425	1427	of	of	IN	B-PP
O	1428	1431	p38	p38	NN	B-NP
O	1431	1432	.	.	.	O

O	1433	1437	This	This	DT	B-NP
O	1438	1447	induction	induction	NN	I-NP
O	1448	1450	of	of	IN	B-PP
O	1451	1454	Ets	Ets	NN	B-NP
O	1454	1455	-	-	HYPH	B-NP
O	1455	1456	1	1	CD	I-NP
O	1457	1460	may	may	MD	B-VP
O	1461	1463	be	be	VB	I-VP
O	1464	1472	relevant	relevant	JJ	B-ADJP
O	1473	1476	for	for	IN	B-PP
O	1477	1497	reendothelialization	reendothelialization	NN	B-NP
O	1498	1500	by	by	IN	B-PP
O	1501	1511	regulating	regulate	VBG	B-VP
O	1512	1515	the	the	DT	B-NP
O	1516	1526	expression	expression	NN	I-NP
O	1527	1529	of	of	IN	B-PP
O	1530	1537	certain	certain	JJ	B-NP
O	1538	1543	genes	gene	NNS	I-NP
O	1543	1544	.	.	.	O

